--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About MIRM20260417C85
Pharmaceutical
Mirum Pharmaceuticals, Inc., was incorporated in Delaware on May 2, 2018. The Company is a biopharmaceutical company focused on identifying, acquiring, developing and commercializing novel therapies for debilitating rare and orphan diseases.
